Isogenic CRISPR anchor screens identified actionable nodes to CHK1/2 inhibitor Prexasertib in TP53 mutant cancer

Press Release

Isogenic CRISPR anchor screens identified actionable nodes to CHK1/2 inhibitor Prexasertib in TP53 mutant cancer